Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty
Status:
Recruiting
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
The goal of this randomized control trial is to in [describe participant population/health
conditions]. The main question it aims to answer is:
• Is the use of intraoperative subpectoral bupivacaine associated with decreased
post-operative pain in adolescent patients who undergo bilateral reduction mammaplasty
Participants will be randomized into the study group that intraoperatively receives 20cc of
subpectoral bupivacaine injections or into the control group that intraoperatively receives
20cc of injectable saline subpectorally. All participants will keep a pain log and pain
medication log at home for the first week following surgery.
Researchers will compare to see if patients who receive subpectoral bupivacaine have lower
pain scores in the PACU, and lower use of narcotics post-operatively when compared to the
control group who receive injectable saline.